Page 2 - Generic Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sun Pharmaceutical Industries rose 1.30% to Rs 699.85 after Life Insurance Corporation of India (LIC) purchased 4.83 crore equity shares or 2.016% stake of the drug major. Post transaction, LIC's stake in Sun Pharma has increased to 7.026% from 5.010% held earlier. The deal was executed as a market purchase between 23 June 2017 to 17 May 2021. On a consolidated basis, the drug major reported an 87.4% jump in net profit to Rs 1,918.11 crore on 9.2% rise in net sales to Rs 8,781.84 crore in Q3 FY21 over Q3 FY20. Sun Pharmaceutical Industries is the world's fourth largest specialty generic phar...

Operator Good day, and thank you for standing by. Welcome to the Endo International plc First Quarter 2021 Earnings Conference Call. [Operator Instructions] Please be advised, today's conference is being recorded. [Operator Instructions] I would now like to hand the conference over to speaker today, Laure Park, Senior Vice President of Investor Relations and Corporate Affairs. Please go ahead. Laure Park -- Senior Vice President of Investor Relations and Corporate Affairs Thank you. Good morning, and thank you for joining us to discuss our first quarter 2021 financial results. Joining me on ...

The drug major said that one of its wholly-owned subsidiaries has agreed to acquire 428,571 ordinary shares (equivalent to 12.5% stake) in WRS Bioproducts, Australia. WRS Bioproducts is an early stage company based in Australia, developing novel technologies to produce and commercialize supplements and nutraceutical ingredients from diverse algae species. The cost of the said acquisition is 2 million Australian dollars and the company expects to complete the same by 15 March 2021. Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutica...

Operator Good morning, ladies and gentlemen, and welcome to the Fourth Quarter 2020 Endo International plc Earnings Conference Call.[Operator Instructions] I would now like to turn the conference over to your host, Ms. Laure Park, Vice President, Investor Relations and Corp Affairs. Please go ahead. Laure Park -- Senior Vice President, Investor Relations and Corporate Affairs Good morning and thank you for joining us to discuss our fourth quarter and full year 2020 financial results. Joining me on today's call are Blaise Coleman, President and CEO of Endo; Mark Bradley, Executive Vice Presid...

Share this article Ray Shelley of Apotex Elected Vice-Chair TORONTO, Feb. 22, 2021 /CNW/ - The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the unanimous election of Mr. Jean-Guy Goulet, Chief Operating Officer of Pharmascience, as Chair of CGPA. Mr. Ray Shelley, Senior Vice President, Commercial Operations – Canada and Caribbean at Apotex Inc., has been unanimously elected as Vice-Chair of CGPA. Mr. Goulet said that, given the lessons learned through maintaining Canada's prescription drug supply through the COVID-19 pandemic, strengthening the domestic industr...